Vonoprazan is noninferior to proton pump inhibitors in bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: A propensity score matching analysis.

Juan Wang,Yue Yue Li,Min Juan Lin,Jing Liu,Bo Shen Lin, Yu Ming Ding,Meng Wan,Wen Lin Zhang,Qing Zhou Kong,Shao Tong Wang, Yi Jun Mu,Miao Duan,Zhong Xue Han,Xiu Li Zuo,Yan Qing Li

Journal of digestive diseases（2023）

引用 0|浏览7

暂无评分

摘要

VPZ-based therapy resulted in a satisfactory eradication rate and was well tolerated for H. pylori eradication, which are comparable to PPIs in C-BQT as a first-line treatment for H. pylori infection.

查看译文

关键词

Helicobacter pylori,bismuth-containing therapy,propensity score matching,proton pump inhibitors,vonoprazan

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要